BRIDGEWAY CAPITAL MANAGEMENT, LLC - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 97 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$534,000
-27.3%
35,000
-41.7%
0.01%
-28.6%
Q2 2018$735,000
-7.7%
60,000
-28.0%
0.01%
-22.2%
Q1 2018$796,000
-41.2%
83,300
-44.4%
0.01%
-40.0%
Q4 2017$1,354,000
+39.9%
149,900
-10.9%
0.02%
+36.4%
Q3 2017$968,000
+227.0%
168,300
+80.4%
0.01%
+175.0%
Q2 2017$296,000
-6.6%
93,3000.0%0.00%0.0%
Q1 2017$317,000
+17.8%
93,3000.0%0.00%0.0%
Q4 2016$269,000
-51.0%
93,3000.0%0.00%
-50.0%
Q3 2016$549,000
+92.0%
93,300
+75.0%
0.01%
+60.0%
Q1 2016$286,000
-61.9%
53,300
-15.8%
0.01%
-64.3%
Q4 2015$751,000
+44.4%
63,3000.0%0.01%
+27.3%
Q3 2015$520,000
-17.2%
63,300
+40.7%
0.01%
-8.3%
Q2 2015$628,000
-41.9%
45,0000.0%0.01%
-45.5%
Q1 2015$1,081,000
+45.9%
45,0000.0%0.02%
+29.4%
Q4 2014$741,00045,0000.02%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 4,080,237$103,638,00010.86%
Aquilo Capital Management, LLC 1,454,686$36,949,0007.45%
RTW INVESTMENTS, LP 7,152,918$181,684,0005.11%
EcoR1 Capital, LLC 2,721,993$69,139,0005.11%
BRIDGER MANAGEMENT, LLC 1,473,568$37,429,0003.47%
DAFNA Capital Management LLC 454,236$11,538,0003.33%
Parkman Healthcare Partners LLC 300,805$7,640,0002.15%
ACUTA CAPITAL PARTNERS, LLC 170,000$4,318,0001.25%
Integral Health Asset Management, LLC 110,000$2,794,0000.84%
DRIEHAUS CAPITAL MANAGEMENT LLC 1,013,087$25,732,0000.63%
View complete list of DICERNA PHARMACEUTICALS INC shareholders